ESR1 and neoplasm: Prognostic and predictive factors are indispensable tools in neoplastic disease treatment [11], and estrogen receptor (ER) concentration is an important parameter in BrC prognosis [12]; ER status is an important consideration for BrC antiestrogen treatment [13].